JFL Life Sciences
Jfl Life Sciences Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in JFL Life Sciences
Start SIPJfl Life Sciences Investment Rating
-
Master Rating:
-
Jfl Life Sciences has an operating revenue of Rs. 128.31 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 11% is healthy, ROE of 24% is exceptional. The company has a debt to equity of 74%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 14 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 143 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2022 |
|---|---|
| Total Revenue Annual Cr | 34 |
| Operating Expenses Annual Cr | 28 |
| Operating Profit Annual in Cr | 5 |
| Depreciation Cr | 0 |
| Interest Annual Cr | 2 |
| Tax Annual Cr | 1 |
| Net Profit Annual Cr | 3 |
Jfl Life Sciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 11
- 20 Day
- 34.44
- 50 Day
- 36.77
- 100 Day
- 39.51
- 200 Day
- 20 Day
- 34.36
- 50 Day
- 38.43
- 100 Day
- 38.87
- 200 Day
Jfl Life Sciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 33.32 |
| Second Resistance | 33.64 |
| Third Resistance | 34.02 |
| RSI | 41.54 |
| MFI | 32.1 |
| MACD Single Line | -1.48 |
| MACD | -1.44 |
| Support | |
|---|---|
| First Resistance | 32.62 |
| Second Resistance | 32.24 |
| Third Resistance | 31.92 |
Jfl Life Sciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 16,000 | 1,600,000 | 100 |
| Week | 10,800 | 1,040,040 | 96.3 |
| 1 Month | 10,375 | 987,493 | 95.18 |
| 6 Month | 13,419 | 1,145,208 | 85.34 |
Jfl Life Sciences Result Highlights
JFL Life Sciences Synopsis
NSE-Medical-Whlsle Drg/Suppl
Jfl Life Sciences belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 33.59 Cr. and Equity Capital is Rs. 8.02 Cr. for the Year ended 31/03/2022. JFL Life Sciences Ltd. is a Public Limited Listed company incorporated on 25/04/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24230GJ2010PLC060417 and registration number is 060417.| Market Cap | 36 |
| Sales | 34 |
| Shares in Float | 0.36 |
| No of funds | |
| Yield |
| Book Value | 2.34 |
| U/D Vol ratio | 0.6 |
| LTDebt / Equity | 74 |
| Alpha | -0.39 |
| Beta | 0.63 |
JFL Life Sciences
| Owner Name | Dec-22 | Sep-22 |
|---|---|---|
| Promoters | 67.47% | 67.47% |
| Individual Investors | 29.89% | 27.69% |
| Others | 2.64% | 4.84% |
JFL Life Sciences Management
| Name | Designation |
|---|---|
| Mr. Smiral Ashwinkumar Patel | Chairman & Managing Director |
| Mr. Manishkumar Jasvantlal Patel | Non Executive Director |
| Mrs. Tejal Smiral Patel | Whole Time Director |
| Ms. Sonu Lalitkumar Jain | Independent Director |
| Ms. Bhavna Shah | Independent Director |
Jfl Life Sciences Forecast
Price Estimates
JFL Life Sciences FAQs
What is Share Price of JFL Life Sciences ?
JFL Life Sciences share price is ₹33 As on 27 March, 2023 | 12:02
What is the Market Cap of JFL Life Sciences ?
The Market Cap of JFL Life Sciences is ₹36.3 Cr As on 27 March, 2023 | 12:02
What is the P/E ratio of JFL Life Sciences ?
The P/E ratio of JFL Life Sciences is As on 27 March, 2023 | 12:02
What is the PB ratio of JFL Life Sciences ?
The PB ratio of JFL Life Sciences is 3.2 As on 27 March, 2023 | 12:02